Akèy › Kansè tete negatif triple › Nevada › Reno
Etid klinik pou Kansè tete negatif triple nan Reno, NV
3 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Reno (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Ap rekriteFaz 3
- Renown Regional Medical Center ( Site 0005), Reno
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Renown Regional Medical Center ( Site 0041), Reno
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Ap rekriteEtid obsèvasyon
- Cancer Care Specialist of Reno, Reno
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Reno
- Kansè Poumon ki pa ti selil16 etid
- Kansè nan tete13 etid
- Kansè poumon9 etid
- Degeneresans makile8 etid
- Atrofi Jeyografik8 etid
- Kansè ovè7 etid
- Kansè (tout kalite)7 etid
- Leksemi mieloïd egi5 etid
- Kansè pankreyas5 etid
- Kansè Metastatik5 etid
- Kansè kolon5 etid
- Kansè kolorektal5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.